SELENOS and Alzheimer disease: Recently, Jang et al. (2017) showed that ubiquitination-dependent C99 degradation was inhibited and that the Aβ1-42 level was significantly increased in a SELENOS-knockdown cell model of AD, indicating that SELENOS participates in the C99 degradation process through ERAD.